Literature DB >> 27571275

Structure of the C-Terminal Helical Repeat Domain of Eukaryotic Elongation Factor 2 Kinase.

Nathan Will1, Andrea Piserchio1, Isaac Snyder1, Scarlet B Ferguson2, David H Giles2, Kevin N Dalby2,3, Ranajeet Ghose1.   

Abstract

Eukaryotic elongation factor 2 kinase (eEF-2K) phosphorylates its only known physiological substrate, elongation factor 2 (eEF-2), which reduces the affinity of eEF-2 for the ribosome and results in an overall reduction in protein translation rates. The C-terminal region of eEF-2K, which is predicted to contain several SEL-1-like helical repeats (SLRs), is required for the phosphorylation of eEF-2. Using solution nuclear magnetic resonance methodology, we have determined the structure of a 99-residue fragment from the extreme C-terminus of eEF-2K (eEF-2K627-725) that encompasses a region previously suggested to be essential for eEF-2 phosphorylation. eEF-2K627-725 contains four helices, of which the first (αI) is flexible, and does not pack stably against the ordered helical core formed by the last three helices (αII-αIV). The helical core is structurally similar to members of the tetratricopeptide repeat (TPR) family that includes SLRs. The two penultimate helices, αII and αIII, comprise the TPR, and the last helix, αIV, appears to have a capping function. The eEF-2K627-725 structure illustrates that the C-terminal deletion that was shown to abolish eEF-2 phosphorylation does so by destabilizing αIV and, therefore, the helical core. Indeed, mutation of two conserved C-terminal tyrosines (Y712A/Y713A) in eEF-2K previously shown to abolish eEF-2 phosphorylation leads to the unfolding of eEF-2K627-725. Preliminary functional analyses indicate that neither a peptide encoding a region deemed crucial for eEF-2 binding nor isolated eEF-2K627-725 inhibits eEF-2 phosphorylation by full-length eEF-2K. Taken together, our data suggest that the extreme C-terminal region of eEF-2K, in isolation, does not provide a primary docking site for eEF-2.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27571275      PMCID: PMC5266509          DOI: 10.1021/acs.biochem.6b00711

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  66 in total

1.  Design of stable alpha-helical arrays from an idealized TPR motif.

Authors:  Ewan R G Main; Yong Xiong; Melanie J Cocco; Luca D'Andrea; Lynne Regan
Journal:  Structure       Date:  2003-05       Impact factor: 5.006

2.  GeneSilico protein structure prediction meta-server.

Authors:  Michal A Kurowski; Janusz M Bujnicki
Journal:  Nucleic Acids Res       Date:  2003-07-01       Impact factor: 16.971

3.  Using NMRView to visualize and analyze the NMR spectra of macromolecules.

Authors:  Bruce A Johnson
Journal:  Methods Mol Biol       Date:  2004

4.  WHAT IF: a molecular modeling and drug design program.

Authors:  G Vriend
Journal:  J Mol Graph       Date:  1990-03

5.  Accurate NMR structures through minimization of an extended hybrid energy.

Authors:  Michael Nilges; Aymeric Bernard; Benjamin Bardiaux; Thérèse Malliavin; Michael Habeck; Wolfgang Rieping
Journal:  Structure       Date:  2008-09-10       Impact factor: 5.006

6.  Impaired associative taste learning and abnormal brain activation in kinase-defective eEF2K mice.

Authors:  Iness Gildish; David Manor; Orit David; Vijendra Sharma; David Williams; Usha Agarwala; Xuemin Wang; Justin W Kenney; Chris G Proud; Kobi Rosenblum
Journal:  Learn Mem       Date:  2012-02-24       Impact factor: 2.460

7.  NMRPipe: a multidimensional spectral processing system based on UNIX pipes.

Authors:  F Delaglio; S Grzesiek; G W Vuister; G Zhu; J Pfeifer; A Bax
Journal:  J Biomol NMR       Date:  1995-11       Impact factor: 2.835

8.  The eEF2 kinase confers resistance to nutrient deprivation by blocking translation elongation.

Authors:  Gabriel Leprivier; Marc Remke; Barak Rotblat; Adrian Dubuc; Abigail-Rachele F Mateo; Marcel Kool; Sameer Agnihotri; Amal El-Naggar; Bin Yu; Syam Prakash Somasekharan; Brandon Faubert; Gaëlle Bridon; Cristina E Tognon; Joan Mathers; Ryan Thomas; Amy Li; Adi Barokas; Brian Kwok; Mary Bowden; Stephanie Smith; Xiaochong Wu; Andrey Korshunov; Thomas Hielscher; Paul A Northcott; Jason D Galpin; Christopher A Ahern; Ye Wang; Martin G McCabe; V Peter Collins; Russell G Jones; Michael Pollak; Olivier Delattre; Martin E Gleave; Eric Jan; Stefan M Pfister; Christopher G Proud; W Brent Derry; Michael D Taylor; Poul H Sorensen
Journal:  Cell       Date:  2013-05-23       Impact factor: 41.582

9.  Resonance assignment of methionine methyl groups and chi 3 angular information from long-range proton-carbon and carbon-carbon J correlation in a calmodulin-peptide complex.

Authors:  A Bax; F Delaglio; S Grzesiek; G W Vuister
Journal:  J Biomol NMR       Date:  1994-11       Impact factor: 2.835

10.  Targeted silencing of elongation factor 2 kinase suppresses growth and sensitizes tumors to doxorubicin in an orthotopic model of breast cancer.

Authors:  Ibrahim Tekedereli; S Neslihan Alpay; Clint D J Tavares; Zehra E Cobanoglu; Tamer S Kaoud; Ibrahim Sahin; Anil K Sood; Gabriel Lopez-Berestein; Kevin N Dalby; Bulent Ozpolat
Journal:  PLoS One       Date:  2012-07-20       Impact factor: 3.240

View more
  3 in total

1.  Solution Structure of the Carboxy-Terminal Tandem Repeat Domain of Eukaryotic Elongation Factor 2 Kinase and Its Role in Substrate Recognition.

Authors:  Andrea Piserchio; Nathan Will; David H Giles; Fatlum Hajredini; Kevin N Dalby; Ranajeet Ghose
Journal:  J Mol Biol       Date:  2019-05-18       Impact factor: 5.469

2.  Structural Dynamics of the Activation of Elongation Factor 2 Kinase by Ca2+-Calmodulin.

Authors:  Nathan Will; Kwangwoon Lee; Fatlum Hajredini; David H Giles; Rinat R Abzalimov; Michael Clarkson; Kevin N Dalby; Ranajeet Ghose
Journal:  J Mol Biol       Date:  2018-05-22       Impact factor: 5.469

Review 3.  Eukaryotic Elongation Factor 2 Kinase (eEF2K) in Cancer.

Authors: 
Journal:  Cancers (Basel)       Date:  2017-11-27       Impact factor: 6.639

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.